(VIANEWS) – New York Community Bancorp (NYCB), XP (XP), DexCom (DXCM) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. New York Community Bancorp (NYCB)
114.1% sales growth and 30.67% return on equity
New York Community Bancorp, Inc. operates as the bank holding company for Flagstar Bank, N.A. that provides banking products and services in the United States. The company's deposit products include interest-bearing checking and money market, savings, non-interest-bearing, and retirement accounts, as well as certificates of deposit. Its loan products comprise multi-family loans; commercial real estate loans; acquisition, development, and construction loans; commercial and industrial loans; one-to-four family loans; specialty finance loans and leases; warehouse loans; and other loans, such as home equity lines of credit, boat and recreational vehicle indirect lending, point of sale consumer loans, and other consumer loans, including overdraft loans. The company also offers cash management products; non-deposit investment and insurance products; and online banking, mobile banking, and bank-by-phone services. It primarily serves individuals, small and mid-size businesses, and professional associations. The company was formerly known as Queens County Bancorp, Inc. and changed its name to New York Community Bancorp, Inc. in November 2000. New York Community Bancorp, Inc. was founded in 1859 and is headquartered in Hicksville, New York.
Earnings Per Share
As for profitability, New York Community Bancorp has a trailing twelve months EPS of $3.82.
PE Ratio
New York Community Bancorp has a trailing twelve months price to earnings ratio of 3.08. Meaning, the purchaser of the share is investing $3.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.67%.
2. XP (XP)
27.4% sales growth and 20.64% return on equity
XP Inc. provides financial products and services in Brazil. It operates XP Platform, an open product platform that provides clients to access investment products in the market comprising brokerage securities, fixed income securities, mutual, hedge, and private equity funds; derivatives and synthetic instruments; credit cards; loan operations/collateralized credit products; pension and social security funds, and life and travel insurance products; and other investment products comprising real estate funds, and equity and debt capital markets solutions, as well as wealth management services. The company offers brokerage and issuer services to institutional and corporate clients. It also manages mutual funds focused on stocks and macro strategies distributed to retail and to institutional clients; funds and managed portfolios for high-net-worth retail clients, and proprietary treasury funds; and passive mutual funds that track market indexes, and mutual and investment funds focused on fixed income, credit, real estate, infrastructure, and other alternative strategies. In addition, the company offers securities brokerage services for institutional and retail investors; interdealer brokerage services for institutional traders; and commercial and investment banking products, such as loan operations and transactions in the foreign exchange markets and deposits, as well as develops and sells financial education courses and events online and in person to retail clients. It offers its sell products and services through its omni-channel distribution network and online portals. XP Inc. was founded in 2001 and is based in Grand Cayman, Cayman Islands.
Earnings Per Share
As for profitability, XP has a trailing twelve months EPS of $1.3.
PE Ratio
XP has a trailing twelve months price to earnings ratio of 20.03. Meaning, the purchaser of the share is investing $20.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.64%.
Yearly Top and Bottom Value
XP’s stock is valued at $26.05 at 11:22 EST, under its 52-week high of $27.71 and way above its 52-week low of $10.30.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 10.3% and 40.6%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
XP’s EBITDA is 2.
3. DexCom (DXCM)
22.1% sales growth and 16.41% return on equity
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, DexCom has a trailing twelve months EPS of $0.84.
PE Ratio
DexCom has a trailing twelve months price to earnings ratio of 117.95. Meaning, the purchaser of the share is investing $117.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.41%.
4. NuVasive (NUVA)
10.7% sales growth and 3.31% return on equity
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, NuVasive has a trailing twelve months EPS of $0.53.
PE Ratio
NuVasive has a trailing twelve months price to earnings ratio of 71.92. Meaning, the purchaser of the share is investing $71.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.31%.
Yearly Top and Bottom Value
NuVasive’s stock is valued at $38.12 at 11:22 EST, way below its 52-week high of $49.53 and higher than its 52-week low of $35.17.
5. Manhattan Associates (MANH)
7.6% sales growth and 76.96% return on equity
Manhattan Associates, Inc. develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations. The company offers Manhattan SCALE, a portfolio of logistics execution solutions that provide trading partner management, yard management, optimization, warehouse management, and transportation execution services; and Manhattan Active, a set of enterprise and store omni-channel solutions. It also provides inventory optimization and planning solutions; maintenance services comprising customer support services and software enhancements; professional services, such as solutions planning and implementation, and related consulting services; and training and change management services. In addition, the company resells computer hardware, radio frequency terminal networks, radio frequency identification chip readers, bar code printers and scanners, and other peripherals. It offers products through direct sales personnel, as well as through partnership agreements with various organizations. The company operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Manhattan Associates, Inc. was founded in 1990 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Manhattan Associates has a trailing twelve months EPS of $2.34.
PE Ratio
Manhattan Associates has a trailing twelve months price to earnings ratio of 81.18. Meaning, the purchaser of the share is investing $81.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 76.96%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Manhattan Associates’s EBITDA is 13.96.
Moving Average
Manhattan Associates’s value is under its 50-day moving average of $192.47 and way above its 200-day moving average of $155.66.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 15.2% and a drop 18.5% for the next.
Volume
Today’s last reported volume for Manhattan Associates is 308586 which is 19.85% below its average volume of 385032.
Previous days news about Manhattan Associates(MANH)
- According to Zacks on Tuesday, 29 August, "Some other top-ranked stocks from the broader technology sector are NVIDIA (NVDA Quick QuoteNVDA – Free Report) , Manhattan Associates (MANH Quick QuoteMANH – Free Report) and CrowdStrike (CRWD Quick QuoteCRWD – Free Report) . ", "NVIDIA and Manhattan Associates each sport a Zacks Rank #1 (Strong Buy), while CrowdStrike carries a Zacks Rank #2 at present. "
- The zacks analyst blog highlights NVIDIA, workday, super micro computer, paylocity holding and manhattan associates. According to Zacks on Tuesday, 29 August, "Stocks recently featured in the blog include: NVIDIA Corp. (NVDA Quick QuoteNVDA – Free Report) , Workday Inc. (WDAY Quick QuoteWDAY – Free Report) , Super Micro Computer Inc. (SMCI Quick QuoteSMCI – Free Report) , Paylocity Holding Corp. (PCTY Quick QuotePCTY – Free Report) and Manhattan Associates Inc. (MANH Quick QuoteMANH – Free Report) ."
6. First Industrial Realty Trust (FR)
7.4% sales growth and 13.29% return on equity
First Industrial Realty Trust, Inc. (NYSE: FR) is a leading fully integrated owner, operator, and developer of industrial real estate with a track record of providing industry-leading customer service to multinational corporations and regional customers. Across major markets in the United States, our local market experts manage, lease, buy, (re)develop, and sell bulk and regional distribution centers, light industrial, and other industrial facility types. In total, we own and have under development approximately 64.1 million square feet of industrial space as of September 30, 2020.
Earnings Per Share
As for profitability, First Industrial Realty Trust has a trailing twelve months EPS of $2.4.
PE Ratio
First Industrial Realty Trust has a trailing twelve months price to earnings ratio of 20.95. Meaning, the purchaser of the share is investing $20.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.29%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 68.1% and a negative 50%, respectively.
Volume
Today’s last reported volume for First Industrial Realty Trust is 857151 which is 3.93% below its average volume of 892288.
Sales Growth
First Industrial Realty Trust’s sales growth is 14.3% for the present quarter and 7.4% for the next.
